THALOMID Trademark

Trademark Overview

On Tuesday, June 3, 2008, a trademark application was filed for THALOMID with the United States Patent and Trademark Office. The USPTO has given the THALOMID trademark a serial number of 77489356. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, January 25, 2018. This trademark is owned by Celgene Corporation. The THALOMID trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of certain cancers; pharmaceutical preparations that modulate the immune system
thalomid

General Information

Serial Number77489356
Word MarkTHALOMID
Filing DateTuesday, June 3, 2008
Status800 - REGISTERED AND RENEWED
Status DateThursday, January 25, 2018
Registration Number3554067
Registration DateTuesday, December 30, 2008
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 14, 2008

Trademark Statements

Description of MarkThe mark consists of a red square bisected by a white swirl design. The word "THALOMID" appears in black letters to the right .
Goods and Servicespharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of certain cancers; pharmaceutical preparations that modulate the immune system
Indication of Colors claimedThe color(s) black, white and red is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 6, 2008
Primary Code005
First Use Anywhere DateThursday, September 1, 2005
First Use In Commerce DateThursday, September 1, 2005

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 25, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, January 25, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, January 25, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, January 25, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 2, 2018TEAS SECTION 8 & 9 RECEIVED
Saturday, December 30, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 2, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, January 2, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 30, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, January 2, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 30, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, December 30, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, October 14, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 24, 2008NOTICE OF PUBLICATION
Tuesday, September 9, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 9, 2008ASSIGNED TO LIE
Thursday, August 28, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 27, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 27, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 27, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 26, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 26, 2008NON-FINAL ACTION E-MAILED
Tuesday, August 26, 2008NON-FINAL ACTION WRITTEN
Tuesday, August 26, 2008ASSIGNED TO EXAMINER
Saturday, June 7, 2008NOTICE OF DESIGN SEARCH CODE MAILED
Friday, June 6, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

thalomid pharmaceutical preparations modulate cancers immune system certain drugs namely cytokine